99 related articles for article (PubMed ID: 2259922)
21. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
22. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
Yildiz F; Zengin N; Engin H; Güllü I; Barista I; Caglar M; Ozyar E; Cengiz M; Gürkaynak M; Zorlu F; Caner B; Atahan IL; Tekuzman G
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):839-46. PubMed ID: 15465201
[TBL] [Abstract][Full Text] [Related]
24. [CEOP regimen in the treatment for non-Hodgkin's lymphoma].
Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140
[TBL] [Abstract][Full Text] [Related]
25. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
[TBL] [Abstract][Full Text] [Related]
26. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
[TBL] [Abstract][Full Text] [Related]
27. Are alkylating agents a necessary component in the therapy of Hodgkin's disease.
Hagemeister FB
Leuk Lymphoma; 1993; 10 Suppl():91-7. PubMed ID: 7683230
[TBL] [Abstract][Full Text] [Related]
28. The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
Hagemeister FB; Purugganan R; Podoloff DA; Hess M; Rodriguez MA; McLaughlin P; Swan F; Romaguera JE; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():59-63. PubMed ID: 8204521
[TBL] [Abstract][Full Text] [Related]
29. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Meistrich ML; Wilson G; Mathur K; Fuller LM; Rodriguez MA; McLaughlin P; Romaguera JE; Cabanillas FF; Ha CS; Lipshultz LI; Hagemeister FB
J Clin Oncol; 1997 Dec; 15(12):3488-95. PubMed ID: 9396402
[TBL] [Abstract][Full Text] [Related]
30. Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).
Dubey P; Wilson G; Mathur KK; Hagemeister FB; Fuller LM; Ha CS; Cox JD; Meistrich ML
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):609-17. PubMed ID: 10701740
[TBL] [Abstract][Full Text] [Related]
31. A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Liang JC; Bailey NM; Gabriel GJ; Kattan MW; Wang RY; Hagemeister FB; Cabanillas FF; Fuller LM
Leuk Lymphoma; 1993 Apr; 9(6):503-8. PubMed ID: 7687918
[TBL] [Abstract][Full Text] [Related]
32. [Can extended induction chemoradiotherapy be effective in the combined treatment of stage IIIB Hodgkin's disease ?].
Kanaev SV; Girshovich MM; Golovanov SG; Gershanovich ML
Vopr Onkol; 2009; 55(5):562-5. PubMed ID: 20020650
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and toxicity of vinblastine, bleomycin, and methotrexate with involved-field radiotherapy in clinical stage IA and IIA Hodgkin's disease: a British National Lymphoma Investigation pilot study.
Bates NP; Williams MV; Bessell EM; Vaughan Hudson G; Vaughan Hudson B
J Clin Oncol; 1994 Feb; 12(2):288-96. PubMed ID: 7509382
[TBL] [Abstract][Full Text] [Related]
34. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Younes A; Fayad L; Rodriguez MA; Hagemeister FB; Barista I; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):36-43. PubMed ID: 12504034
[TBL] [Abstract][Full Text] [Related]
35. Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation.
Horning SJ; Hoppe RT; Mason J; Brown BW; Hancock SL; Baer D; Rosenberg SA
J Clin Oncol; 1997 May; 15(5):1736-44. PubMed ID: 9164180
[TBL] [Abstract][Full Text] [Related]
36. Controversies in radiotherapy for pediatric Hodgkin's lymphoma.
Wiegner EA; Donaldson SS
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1357-66. PubMed ID: 22029056
[TBL] [Abstract][Full Text] [Related]
37. [Immediate hematologic tolerance of extended irradiations after chemotherapy. Apropos of 78 cases of Hodgkin's disease stage III and IV without marrow involvement treated at the Gustave-Roussy Institute].
Pierga JY; Follezou JY; Chelfi M; Girinsky T; Socie G; Hayat M; Cosset JM
Bull Cancer; 1991; 78(10):921-9. PubMed ID: 1768937
[TBL] [Abstract][Full Text] [Related]
38. Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease. Early results in 100 consecutive patients. Pierre-et-Marie-Curie Group.
Hoerni B; Orgerie MB; Eghbali H; Blanc CM; David B; Rojouan J; Zittoun R
J Cancer Res Clin Oncol; 1991; 117(4):377-80. PubMed ID: 1712359
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity.
Hill M; Milan S; Cunningham D; Mansi J; Smith I; Catovsky D; Gore M; Zulian G; Selby P; Horwich A
J Clin Oncol; 1995 Feb; 13(2):387-95. PubMed ID: 7844599
[TBL] [Abstract][Full Text] [Related]
40. [Possibilities of treatment reduction in Hodgkin's disease (author's transl)].
Teillet F; Delbrück H; Bayle-Weisgerber C; Andrieu JM; Clot P
Dtsch Med Wochenschr; 1979 Oct; 104(40):1405-9. PubMed ID: 498955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
